A BILL 
To direct the Secretary of Veterans Affairs to seek to enter 
into an agreement with a federally funded research and 
development center to conduct surveys to measure can-
nabis use by veterans, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘VA Survey of Cannabis 
4
Use Act’’. 
5
SEC. 2. SURVEY ON CANNABIS USE BY VETERANS. 
6
(a) IN GENERAL.—The Secretary of Veterans Affairs 
7
shall seek to enter into an agreement with a federally 
8
00:27 May 22, 2019
H2676
2 
•HR 2676 IH
funded research and development center to conduct sur-
1
veys nationwide to measure cannabis use by veterans. 
2
(b) SELECTION.—The Secretary shall select a feder-
3
ally funded research and development center under sub-
4
section (a) from among such centers that have— 
5
(1) expertise and a record of independent, peer- 
6
reviewed publications with respect to— 
7
(A) behavioral health research; and 
8
(B) conducting independent evaluations of 
9
mental health programs using multidisciplinary 
10
methods; and 
11
(2) an in-depth knowledge of all State medicinal 
12
marijuana programs and the ability to tailor the sur-
13
veys under subsection (a) accordingly. 
14
(c) CONDUCT OF SURVEYS.—The surveys conducted 
15
under subsection (a) shall meet the following criteria: 
16
(1) One survey shall collect information from 
17
veterans who use cannabis, including both veterans 
18
enrolled in the health care system established under 
19
section 1705(a) of title 38, United States Code, and 
20
veterans who are not so enrolled. 
21
(2) One survey shall collect information from 
22
health care providers of the Department of Veterans 
23
Affairs. 
24
00:27 May 22, 2019
H2676
3 
•HR 2676 IH
(3) Each survey shall be conducted in a manner 
1
that ensures the anonymity of the individual being 
2
surveyed. 
3
(d) MATTERS SURVEYED.— 
4
(1) VETERANS.—The survey described in sub-
5
section (c)(1) shall cover the following subjects: 
6
(A) The current medicinal cannabis use by 
7
the veteran, or the intent or desire by the vet-
8
eran to use medicinal cannabis, and the reasons 
9
for such use, intent, or desire. 
10
(B) The conditions, symptoms, or both, 
11
that the veteran uses cannabis to treat. 
12
(C) The types of cannabis and cannabis 
13
products used by the veteran, including with re-
14
spect to— 
15
(i) tetrahydrocannabinol or cannabidi-
16
ol content; 
17
(ii) indica, sativa, mixes, or hybrids; 
18
and 
19
(iii) flower, oils, hash or kief, con-
20
centrates (wax, shatter, budder), edibles, 
21
drinks, tinctures, and topical ointments. 
22
(D) Other medications taken by the vet-
23
eran concurrently with cannabis and any medi-
24
00:27 May 22, 2019
H2676
4 
•HR 2676 IH
cations the veteran stopped using because of 
1
the use of cannabis. 
2
(E) How the veteran is self-administering 
3
medicinal cannabis, including— 
4
(i) the method; 
5
(ii) the typical times each day the vet-
6
eran self-administers; 
7
(iii) the frequency of different prod-
8
ucts per day and for what condition, symp-
9
tom, or both; and 
10
(iv) the amounts per product. 
11
(F) The ratings and descriptions of the ef-
12
fectiveness of using cannabis to treat condi-
13
tions, symptoms, or both. 
14
(G) Any experiences with side effects. 
15
(H) The number of different cannabis 
16
products tried before settling on the current 
17
product. 
18
(I) The typical source of medical cannabis 
19
(such as a single dispensary, multiple dispensa-
20
ries, mail order, or other source), the typical 
21
purchase frequency, and the typical amount 
22
purchased. 
23
(J) The sources of information the veteran 
24
uses for products and dosages. 
25
00:27 May 22, 2019
H2676
5 
•HR 2676 IH
(K) Factors that influence the choice of 
1
the veteran for using a chosen product (such as 
2
with respect to the levels of tetrahydrocannabi-
3
nol or cannabidiol content, cost, availability, 
4
consistency, or strain). 
5
(L) Any other matters determined appro-
6
priate. 
7
(2) HEALTH CARE PROVIDERS.—The survey de-
8
scribed in subsection (c)(2) shall cover the following 
9
subjects: 
10
(A) A description of the experience of the 
11
health care provider with respect to patients 
12
using medicinal cannabis. 
13
(B) A description by the health care pro-
14
vider of how medicinal cannabis is changing pa-
15
tients. 
16
(C) A description of how treatment plans 
17
have been modified after a veteran discloses 
18
using cannabis. 
19
(D) Any documentation of the products, 
20
dosages, or frequency of such cannabis use in 
21
the medical records of the veteran. 
22
(E) Reporting of adverse events. 
23
(F) The sources of information used by the 
24
health care provider with respect to cannabis 
25
00:27 May 22, 2019
H2676
6 
•HR 2676 IH
products and the medical effectiveness of can-
1
nabis. 
2
(G) Any other matters determined appro-
3
priate. 
4
(e) REPORT.—Not later than one year after the date 
5
of the enactment of this Act, the Secretary shall submit 
6
to the Committees on Veterans’ Affairs of the Senate and 
7
the House of Representatives a report on the results of 
8
the surveys conducted under this section. 
9
Æ 
00:27 May 22, 2019
H2676
